Corbus Pharmaceuticals
CRBP
#8619
Rank
โ‚น16.39 B
Marketcap
โ‚น934.23
Share price
1.27%
Change (1 day)
-27.60%
Change (1 year)

Revenue for Corbus Pharmaceuticals (CRBP)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corbus Pharmaceuticals from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A-100%
2021 โ‚น65.62 M-77.21%
2020 โ‚น0.28 B-88.83%
2019 โ‚น2.57 B664.4%
2018 โ‚น0.33 B116.41%
2017 โ‚น0.15 B19.95%
2016 โ‚น0.12 B201.45%
2015 โ‚น43.08 M
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Vanda Pharmaceuticals
VNDA
โ‚น19.10 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Viking Therapeutics
VKTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
โ‚น4.77 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS
โ‚น10.27 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA